Twist Bioscience Corp (TWST): Capital Expenditures
$28.00M
Year ended 2025-09-30
$40.05M
Trailing 12 months to 2026-06-30
-35.0%
3-year compound annual growth
+23.2%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $28.00M | +451.7% | 2025-11-17, From 2024-10-01 |
| 2024-09-30 | $5.08M | -81.7% | 2025-11-17, From 2023-10-01 |
| 2023-09-30 | $27.78M | -72.7% | 2025-11-17, From 2022-10-01 |
| 2022-09-30 | $101.86M | +276.4% | 2024-11-18, From 2021-10-01 |
| 2021-09-30 | $27.06M | +174.2% | 2023-11-21, From 2020-10-01 |
| 2020-09-30 | $9.87M | -33.1% | 2023-06-05, From 2019-10-01 |
| 2019-09-30 | $14.76M | +300.1% | 2021-11-23, From 2018-10-01 |
| 2018-09-30 | $3.69M | -44.1% | 2020-11-27, From 2017-10-01 |
| 2017-09-30 | $6.59M | n/a | 2019-12-13, From 2016-10-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | 2025-09-30 | $28.00M | +451.7% |
| Krystal Biotech, Inc. (KRYS) | 2025-12-31 | $11.95M | +182.0% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | $4.34M | -16.1% |
| Tarsus Pharmaceuticals, Inc. (TARS) | 2025-12-31 | $9.86M | +529.2% |
| ADMA Biologics, Inc. (ADMA) | 2025-12-31 | $22.57M | +174.4% |
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | $2.96M | -19.2% |
| Vericel Corp (VCEL) | 2025-12-31 | $27.16M | -57.5% |
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | $33.84M | +205.7% |
| Vaxart, Inc. (VXRT) | 2025-12-31 | $145.0K | -73.8% |
Compare TWST, KRYS, IMCR, TARS side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗